SEC 13F Intelligence

Paradigm Capital Management Inc/Ny / GNMK

Paradigm Capital Management Inc/Ny’s Genmark Diagnostics Inc Position

Does Paradigm Capital Management Inc/Ny own Genmark Diagnostics Inc (GNMK)? Not currently — the last reported position was 733.3K shares worth $18M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q1 2021
Shares
733.3K
% of Portfolio
+0.91%
Quarters Held
10
position exited

Position History GNMK

Reported value by quarter
Q4 ’18: $96,000Q4 ’18Q1 ’19: $140,000Q2 ’19: $127,000Q2 ’19Q3 ’19: $271,000Q4 ’19: $481,000Q4 ’19Q1 ’20: $489,000Q2 ’20: $3MQ2 ’20Q3 ’20: $3MQ4 ’20: $9MQ4 ’20Q1 ’21: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021733.3K$18M+0.91%
Q4 2020620.8K$9M+0.54%
Q3 2020196.1K$3M+0.23%
Q2 2020193.7K$3M+0.26%
Q1 2020118.7K$489,000+0.06%
Q4 2019100.1K$481,000+0.04%
Q3 201944.7K$271,000+0.02%
Q2 201919.7K$127,000+0.01%
Q1 201919.7K$140,000+0.01%
Q4 201819.7K$96,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Paradigm Capital Management Inc/Ny’s full portfolio or all institutional holders of GNMK.